All Stories

  1. AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation
  2. Preclinical evaluation of AVN-322, novel and highly selective 5-HT6 receptor antagonist, for the treatment of Alzheimer's disease
  3. 5-HT7 receptor antagonist with a potential to treat multiple CNS diseases
  4. Synthesis of substituted diphenyl sulfones and their structure–activity relationship with the antagonism of 5-НТ6 receptors
  5. 3,6-Diamino-4-(2-halophenyl)-2-benzoylthieno[2,3- b ]pyridine-5-carbonitriles Are Selective Inhibitors of Plasmodium falciparum Glycogen Synthase Kinase-3
  6. Antagonists of 5-HT6 receptors. Substituted 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[3,4-e]pyrimidines and 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[4,3-d]pyrimidines—Synthesis and ‘structure–activity’ relationship
  7. Synthesis and Structure–Activity Relationship (SAR) of (5,7-Disubstituted 3-phenylsulfonyl-pyrazolo[1,5- a ]pyrimidin-2-yl)-methylamines as Potent Serotonin 5-HT 6 Receptor (5-HT 6 R) Antagonists
  8. ChemInform Abstract: 2-Substituted 5,6-Dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: New Series of Highly Potent and Specific Serotonin 5-HT6 Receptor Antagonists.
  9. A Novel Synthetic Smoothened Antagonist Transiently Inhibits Pancreatic Adenocarcinoma Xenografts in a Mouse Model
  10. 2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: New series of highly potent and specific serotonin 5-HT6 receptor antagonists
  11. Synthesis and SAR of 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines as potent serotonin 5-HT6 receptor antagonists
  12. (3-Phenylsulfonylcycloalkano[ e and d ]pyrazolo[1,5- a ]pyrimidin-2-yl)amines: Potent and Selective Antagonists of the Serotonin 5-HT 6 Receptor
  13. Solution Phase Parallel Synthesis of Substituted 3-Phenylsulfonyl-[1,2,3]triazolo[1,5- a ]quinazolines: Selective Serotonin 5-HT 6 Receptor Antagonists
  14. Synthesis and biological study of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines as potent and selective serotonin 5-HT6 receptor antagonists
  15. ChemInform Abstract: 8-Sulfonyl-Substituted Tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 Receptor Antagonists.
  16. Synthesis of cycloalkane-annelated 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines and their evaluation as 5-HT6 receptor antagonists
  17. 8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonists
  18. Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles
  19. Synthesis and biological evaluation of novel γ-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists
  20. Nonpeptide Small Molecule Inhibitors of Caspases
  21. Novel aryl and heteroaryl substituted N-[3-(4-phenylpiperazin-1-yl)propyl]-1,2,4-oxadiazole-5-carboxamides as selective GSK-3 inhibitors
  22. Caspase Activity Modulators as Anticancer Agents
  23. Synthesis and Chemical Transformations of 6-(Morpholine-4-sulfonyl)-quinoline-2,3,4-tricarboxylic Acid.
  24. Pyrrolo[3,4-c]quinoline-1,3-diones as Potent Caspase-3 Inhibitors. Synthesis and SAR of 2-Substituted 4-Methyl-8-(morpholine-4-sulfonyl)-pyrrolo[3,4-c]quinoline-1,3-diones.
  25. Synthesis and Chemical Transformations of 6‐(Morpholine‐4‐sulfonyl)‐quinoline‐2,3,4‐tricarboxylic Acid
  26. Synthesis and Caspase-3 Inhibitory Activity of 8-Sulfonyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines.
  27. Pyrrolo[3,4-c]Quinoline-1,3-Diones as Potent Caspase-3 Inhibitors: Synthesis and SAR of 8-Sulfamoyl-1,3-Dioxo-2,3-Dihydro-1H-Pyrrolo[3,4- c]Quinolines
  28. NEW VARIANT OF THE PEIZINGER REACTION. SYNTHESIS AND CHEMICAL TRANSFORMATIONS OF SUBSTITUTED 2-AMINOMETHYL-QUINOLINE-3,4-DICARBOXYLIC ACIDS
  29. Pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors. Synthesis and SAR of 2-substituted 4-methyl-8-(morpholine-4-sulfonyl)-pyrrolo[3,4-c]quinoline-1,3-diones
  30. Synthesis and caspase-3 inhibitory activity of 8-sulfonyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines
  31. 1,3-Dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines as Potent Caspase-3 Inhibitors.
  32. Synthesis and Structure−Activity Relationship of 4-Substituted 2-(2-Acetyloxyethyl)-8-(morpholine- 4-sulfonyl)pyrrolo[3,4- c ]quinoline- 1,3-diones as Potent Caspase-3 Inhibitors
  33. 1,3-Dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines as potent caspase-3 inhibitors
  34. Efficient Optimization Strategy for Marginal Hits Active Against abl Tyrosine Kinases
  35. Property-Based Design of GPCR-Targeted Library.
  36. Property-Based Design of GPCR-Targeted Library
  37. Serotonin Antagonist Profiling on 5HT2A and 5HT2C Receptors by Nonequilibrium Intracellular Calcium Response Using an Automated Flow-Through Fluorescence Analysis System, HT-PS® 100
  38. High-throughput pharmocology system HT-PS 100: instrument for automated quantitative analysis of a ligand-receptor interaction based on ligand concentration-dependent functional responses in cells
  39. Functional characterization of naturally expressed G-protein-coupled receptors in mammalian cells using the automated high-throughput pharmacological system HT-PS 100
  40. The discovery and structure—activity relationships of nonpeptide, low molecular weight antagonists selective for the endothelin ETB receptor
  41. 2-Aryloxycarbonylthiophene-3-sulfonamides: Highly potent and etA selective endothelin receptor antagonists
  42. Structure−Activity Relationships of N   2 -Aryl-3-(isoxazolylsulfamoyl)-2-thiophenecarboxamides as Selective Endothelin Receptor-A Antagonists 1
  43. Discovery of TBC11251, a Potent, Long Acting, Orally Active Endothelin Receptor-A Selective Antagonist 1
  44. New methods to mimic nature in high-throughput screening
  45. Search for surrogates: A study of endothelin receptor antagonist structure activity relationships
  46. Amide bond surrogates: A study in thiophenesulfonamide based endothelin receptor antagonists
  47. Thiophenesulfonamides as endothelin receptor antagonists
  48. Halogen substitution at the isoxazole ring enhances the activity of N-(isoxazolyl)sulfonamide endothelin antagonists